- (PLX AI) – Zealand Pharma says net product revenue from the sales of commercial products is expected to be DKK 190 million +/- 10% for the full year.
- • This is a decrease of DKK 30 million from the guidance issued on March 11, 2021
- • The reduction in net revenue from the previous guidance is driven by lower-than-expected sales of Zegalogue for 2021, the company said